CTTH — CTT Pharmaceutical Holdings Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $3.24m
- $3.21m
Annual income statement for CTT Pharmaceutical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2010 December 31st | 2011 December 31st | 2012 December 31st | R2013 December 31st | 2014 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.58 | 0.766 | 1.19 | 0.019 | 0.672 |
| Operating Profit | -1.58 | -0.766 | -1.19 | -0.019 | -0.672 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.1 | 3.74 | -1 | -0.019 | -0.672 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.1 | 3.74 | -1 | -0.019 | -0.672 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.1 | 3.74 | -1 | -0.019 | -0.672 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -1.1 | 3.74 | -1 | -0.019 | -0.672 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.87 | -2.41 | -0.96 | -0.001 | -0.041 |
| Dividends per Share |